Observational studyAnnals of surgical oncology2026
Association between Surgical Waiting Time and Postoperative Recurrence Risk in Clinical T1bN0M0 Thoracic Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Observational Study.
Observational study in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ASO Author Reflections: What is the Oncologically Acceptable Surgical Waiting Time in Patients with cT1bN0M0 Squamous Cell Carcinoma of the Thoracic Esophagus?Annals of surgical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough prompt treatment is desirable for malignancies, surgical delays are sometimes unavoidable. Previous studies show conflicting results on the effect of diagnosis-to-surgery delay in esophageal cancer, mainly focusing on advanced stages treated preoperatively. Early stage disease, particularly cT1bN0, often involves longer waiting times, but the acceptable delay remains unclear. We conducted this study to evaluate the impact of surgical waiting time on postoperative survival in patients with clinical T1bN0M0 esophageal squamous cell carcinoma (ESCC) undergoing upfront esophagectomy. PATIENTS AND
methodsThis multicenter retrospective study included 160 patients with cT1bN0M0 ESCC undergoing subtotal esophagectomy with lymphadenectomy at seven Japanese institutions between 2008 and 2021. Receiver operating characteristic (ROC) analysis identified the optimal waiting time cutoff predicting recurrence. Survival outcomes were compared between short and long waiting groups using the Kaplan-Meier method and Cox regression analyses.
resultsROC analysis identified 66.5 days as the optimal cutoff value. The long waiting group (≥ 67 days) showed significantly worse 3-year recurrence-free survival (87.9% versus 73.5%, log-rank P < 0.01; hazard ratio 2.71, 95% confidence interval 1.29-5.70, P < 0.01), whereas cancer-specific survival showed no significant difference. Multivariate analysis identified prolonged waiting time, pathological T2 or deeper invasion, and lymph node metastasis as independent predictors of recurrence, with longer delays linked to increased systemic recurrence beyond 2 years postoperatively.
conclusionsIn patients with cT1bN0 ESCC, surgical delay beyond approximately 2 months independently increases postoperative recurrence. It is suggested that planning surgery without delay reduces the risk of recurrence; however, verification in a larger cohort is necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.